Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
44.46
-1.23 (-2.69%)
At close: Nov 13, 2026, 4:00 PM EST
44.20
-0.26 (-0.58%)
After-hours: Nov 13, 2026, 7:30 PM EST
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Rigel Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $64.4. The average 1-year stock price forecast is 44.85% higher than the current stock price, while the lowest is $47 (+5.71%) and the highest is $86 (+93.43%).
Price Target: $64.4 (+44.85%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $47 | Hold | Maintains | $47 | +5.71% | Nov 9, 2026 |
| Citi | Citi | Buy Maintains $83 → $86 | Buy | Maintains | $83 → $86 | +93.43% | Nov 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $85 | Buy | Reiterates | $85 | +91.18% | Nov 4, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $49 | Hold | Maintains | $49 | +10.21% | Oct 21, 2026 |
Financial Forecast
Revenue This Year
305.37M
from 294.28M
Increased by 3.77%
Revenue Next Year
365.50M
from 305.37M
Increased by 19.69%
EPS This Year
3.58
from 6.43
Decreased by -44.28%
EPS Next Year
4.91
from 3.58
Increased by 37.11%
EPS and Forward PE are based on non-GAAP adjusted numbers.